Generate:Biomedicines's banner

Generate:Biomedicines

@generate_biomed • 6,789 subscribers

As pioneers in generative biology, we're revolutionizing the way biotherapeutics are discovered and developed.

Shorts

Today we announced that we raised $273 million in Series C financing to advance our preclinical & clinical pipeline. We’re proud to have the confidence of our investors, including all Series B investors, who believe we are revolutionizing drug development:

Today we announced that we raised $273 million in Series C financing to advance our preclinical & clinical pipeline. We’re proud to have the confidence of our investors, including all Series B investors, who believe we are revolutionizing drug development:

31,631 views

GB-0895, our anti-TSLP monoclonal antibody, has entered a Phase 1 clinical trial for chronic obstructive pulmonary disease (COPD)—its second indication following asthma. Designed using generative optimization, GB-0895 was built for high potency, extended half-life, and targeted function. This is the fourth clinical trial for a molecule designed on our platform and reflects how generative optimization can produce antibodies with defined therapeutic properties that advance efficiently into clinical development. Learn more:

GB-0895, our anti-TSLP monoclonal antibody, has entered a Phase 1 clinical trial for chronic obstructive pulmonary disease (COPD)—its second indication following asthma. Designed using generative optimization, GB-0895 was built for high potency, extended half-life, and targeted function. This is the fourth clinical trial for a molecule designed on our platform and reflects how generative optimization can produce antibodies with defined therapeutic properties that advance efficiently into clinical development. Learn more:

10,481 views

Videos

Anya Rossi

sweetdream.ai

SweetDream.ai•Sponsored•Livecam

Watch Anya Live

Anya is streaming live right now! Join her private show and enjoy exclusive content.

Exclusive private shows

1.2k viewers online

Private Show

Join now for exclusive access

Free preview available • Premium content

Today, we announced the opening of our 70K sq ft CryoEM lab in Andover, Mass – among the largest privately owned labs of its kind in the U.S. – which will help drive faster and more efficient therapeutic development. Take an up-close look at the space:

Today, we announced the opening of our 70K sq ft CryoEM lab in Andover, Mass – among the largest privately owned labs of its kind in the U.S. – which will help drive faster and more efficient therapeutic development. Take an up-close look at the space:

Generate:Biomedicines

17,124 views • 3 years ago

No more content to load